GNH USA

Europe — EMA

Olmesartán/Hidroclorotiazida Vir (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Vir, is an angiotensin II receptor blocker presented as a tablet for oral use.

Request sourcing

1
Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Vir, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartán/Hidroclorotiazida Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartán/Hidroclorotiazida Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmesartan/Hydrochlorothiazide is used in the management of cardiovascular conditions that involve fluid retention and elevated blood pressure.

- Hypertension: Lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Congestive heart failure: Assists  by  reducing fluid overload and easing cardiac workload. - Edema associated with renal disease or liver cirrhosis :  helps  to  promote  diuresis  and  decrease  fluid  retention  in  these  conditions. - Chronic  d  S  ​                       …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Olmesartan Medoxomil, Hydrochlorothiazide
Route
Oral Use
Manufacturer
Industria Química Y Farmaceútica Vir, S.A.
Origin
EU

Related products